Septal myectomy: Cut, coil, or boil?

European Heart Journal

Volumn 29, Issue 3, 2008, Pages 296-298

  Togni, Mario ^a   Billinger, Michael ^a   Cook, Stephane ^a   Hess, Otto M ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

COIL EMBOLIZATION; EDITORIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE RESECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHY, HYPERTROPHIC; EMBOLIZATION, THERAPEUTIC; HUMANS; STENTS;

EID: 38849086661     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm561     Document Type: Editorial

References (15)

1. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006;114:2232-2239.
2. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007;298:405-412.
3. Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 1995;92(Suppl):II122-127.
4. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214.
5. Durand E, Mousseaux E, Coste P, Pillière R, Dubourg O, Trinquart L, Chatellier G, Hagège A, Desnos M, Lafont A. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomoypathy: early and 6 months follow-up. Eur Heart J 2008;29:348-355. doi:10.1093/eurheartj/ehm632.
6. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED, Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/ European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-1713.
7. Iacob M, Pinte F, Tintoiu I, Cotuna L, Caroescu M, Popa A, Cristian G, Goleanu V, Greere V, Moscaliuc I, Neagoe G, Crisan P, Garjeu A, Chiriac L, Bolohan R, Murgu V, Lobont B, Filip S, Roates J, Hila G, Postolea E. Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. Kardiol Pol 2004;61:350-355.
8. Chang SM, Nagueh SF, Spencer WH 3rd, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol 2003;42:296-300.
9. Osterne EC, Seixas TN, Paulo Filho W, Osterne EM, Gomes OM. Percutaneous transluminal septal alcoholization for the treatment of refractory hypertrophic obstructive cardiomyopathy: initial experience in the Federal District. Arq Bras Cardiol 2003;80:359-378.
10. Chang SM, Lakkis NM, Franklin J, Spencer WH 3rd, Nagueh SF. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation 2004;109:824-827.
11. Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H. Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients. Heart 2004;90:638-644.
12. Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, Dearani JA, Schaff HV, Holmes DR Jr. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol 2004;44:2329-2332.
13. Faber L, Seggewiss H, Gietzen FH, Kuhn H, Boekstegers P, Neuhaus L, Seipel L, Horstkotte D. Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol 2005;94:516-523.
14. Fernandes VL, Nagueh SF, Wang W, Roberts R, Spencer WH 3rd. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy - the Baylor experience (1996-2002). Clin Cardiol 2005;28:124-130.
15. Streit S, Walpoth N, Windecker S, Meier B, Hess OM. Is alcohol ablation of the septum associated with recurrent tachyarrhthymias. Swiss Med Wkly 2007; in press.